Zavrantonas remains silent in drug retrial as closing arguments set for November 17

Coverage spans the spectrum: 33% left, 33% center, 33% right. Cross-spectrum coverage is a positive signal — the core facts are broadly accepted. Compare how each side headlines it to understand the editorial framing.